The gene-editing solution is in its infancy, and with a vast market opportunity, CRISPR Therapeutics is the stock I am buying today.
Jun 10, 2021
Within the biotech industry there is both high risk, but also high reward; but, is CRISPR or Invitae the better investment right now?
May 28, 2021
We take care of the first one so you can focus on the other two!
After having a stellar 2020 so far, is the Ark Innovation ETF going to continue on its market-beating run?
Jul 28, 2020